reviewCurrent Opinion in Chemical BiologyJul 20, 2010Closed access

Antibody–drug conjugates: targeted drug delivery for cancer

Seagen (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

650
total citations
FWCI
28.35
Percentile
100%
References
53
Citations per year

Authors

3

Topics & keywords

Keywords
  • Brentuximab vedotin
  • Trastuzumab
  • Drug
  • Medicine
  • Pharmacokinetics
  • Antibody-drug conjugate
  • Calicheamicin
  • Biodistribution
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.